Skip to main content
FinSpry Logo
FinSpry
ARWR logo
ARWR
(NASDAQ)
Arrowhead Pharmaceuticals, Inc.
$86.78-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Arrowhead Pharmaceuticals (ARWR) Stock Price & Financial Analysis

Arrowhead Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$86.26 - $89.15
52-Week High$95.49
52-Week Low$15.01
Open$88.72
Volume2.48M
Average Volume (3M)2.79M
Market Cap12.36B
Shares Outstanding142.42M
Price to Sales (P/S)19.87
Price to Book (P/B)20.13
EV/EBITDA-91.40
Revenue (TTM)622.01M
Net Income (TTM)-300.91M
Free Cash Flow (TTM)-50.87M
EPS (TTM)$-2.16
Profit Margin-48.38%
Operating Margin-35.67%
Return on Equity (ROE)-49.01%
Debt to Equity2.24
50-Day MA$77.68
200-Day MA$63.71
52-Week Change445.10%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Arrowhead Pharmaceuticals

What is the current stock price for ARWR?

As of the latest trading session, ARWR stock trades at $86.78. The 52-week range is $15.01–$95.49, with a day range of $86.26–$89.15.

What is the P/E ratio for ARWR?

The P/E ratio (Price-to-Earnings) for ARWR is shown in the Key Statistics section. This valuation metric helps compare Arrowhead Pharmaceuticals, Inc. to industry peers.

Does ARWR pay dividends?

Arrowhead Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ARWR?

Based on 12 analysts, the consensus for ARWR is Buy.

What is the market cap of ARWR?

Arrowhead Pharmaceuticals's market capitalization is $12.36B, classifying it as a large-cap company. Arrowhead Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.